Sanidad Privada 29 - Mayo 2021 by isanidad

Sanidad Privada Nº 29 Mayo 2021

CUATRO DE CADA CINCO ESPAÑOLES AUMENTARÍAN LA PARTIDA DE PRESUPUESTOS DEDICADA A SANIDAD

Marta Villanueva (Fundación IDIS): Necesitamos reformar entre todos un sistema sanitario anclado en el tiempo

De la elección de plaza MIR a la vacunación, un Ministerio de “éxitos”

"#$%&'( #')( *+( ,'-,*./$0-( #')1.%( %/( ".2( %3$4%-5%6( 7'/( 89:$5'/;( 4%*( <$-$/5%)$'( 3$%-%-( 4%( *%='/>( ,'-,)%5+"%-5%>( 4%/4%( 1.%( /'-( /%*%,,$'-+4'/( #+)+( %*( ,+)?'( 4%( <$-$/5)'( #%)/'-+/( 1.%( -'( /+@%-( -+4+( 4%( /+-$4+46( A$( /%(#'-%(+*(B)%-5%(4%*(<$-$/5%)$'(+(+*?.$%-(1.%( -'( ,'-',%( *+( /+-$4+4>( %/( -')"+*( 1.%( **%?.%-( *'/(#)'@*%"+/(1.%(%/5+"'/(3$%-4'(%/5'/(4C+/6

#')(.-'(+.5'"M5$,'>(**+"M-4'*%(5%*%"M5$,'( 2(-'(/%(E+(,'-5+4'(,'-(*'/(#)'B%/$'-+*%/6(!*( ,+"@$'( #.%4%( +#.-5+)/%( %-( *+( *$/5+( 4%( 9:$F 5'/( 4%*( <$-$/5%)$'( %-( %/5'/( S*5$"'/( +T'/6

;.% 5.82).8(<)% 8,)% =#*+.>")"8.% -% &.% "&"88(<)%$"%6&.?.%'@A%#,)%72"#*+.#% $"%"++,+"#%12"%#"%62"$")%8,7"*"+

D'-(*+(4%(B)%-5%/(1.%(E+2(+@$%)5'/(,'"'(%*(D'F 3$4>(*+/(=.@$*+,$'-%/>(*+/(+?)%/$'-%/>(*+(B+*5+(4%( "'5$3+,$0-(2(4%(#)%/.#.%/5'('("%=')+(4%*(/$/F 5%"+>(G+(1.9(3$%-%(.-(,+"@$'(5+-()+4$,+*(%-(*+( %*%,,$0-(4%(#*+&+(<HIJ(K%/4%(%*(<$-$/5%)$'(2+( 4%@%)C+-(/+@%)(1.%(*'/(9:$5'/(-'(3$%-%-(.-$4'/( +(*+(#'*9"$,+>(/$-'(+*(+#'2'(4%(*'/(#)'B%/$'-+F *%/6(A$(E+,%(B+*5+(.-+(,'"$/$0-(4%(%:#%)5'/(#+)+( %*(D'3$4>(#+)+(*'/(,+"@$'/(%-(%*(<HI(5+"@$9-6

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

12"%&,#%34(*,#%),%5(")")%2)($,#% .%&.%6,&37(8.9%#(),%.&%.6,-,% $"%&,#%6+,:"#(,).&"#

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

A$-( %"@+)?'>( #'-%)( %-( 4.4+( *+( %B%,5$3$4+4( 4%(.-+(3+,.-+(%-(.-("'"%-5'(5+-($"#')F 5+-5%( -'( %/( )+&'-+@*%6( 7'( "%=')( /%)C+( %:F #*$,+)( *'/( 3%)4+4%)'/( "'5$3'/( 4%*( )%,E+&'( +( %/5+( 3+,.-+6( 7+( 5)+-/#+)%-,$+( %/( @M/$,+( %-( %/5'/( "'"%-5'/( 4%( *+( E$/5')$+( #+)+( #'F 4%)(5)+-/"$5$)(,'-O+-&+>(2(%*(<$-$/5%)$'(-'( *'( %/5M( /$%-4'( 4%( "'"%-5'6 Q'(%/(+*?'(-.%3'(4%(D+F )'*$-+(K+)$+/6(A+*3+4')( H**+( '( K'*')/( <'-5/%F ))+5( 5+"#','( B')"+F )M-(#+)5%(4%(*'/(<$-$/F 5)'/( 4%( A+-$4+4( 85'#;6

2$/)".%"3(0+ 4/0%*'+0"-%,%0(&".%"5)(,/.(. Abril 2021. Sanidad Privada · www.isanidad.com · Página 3

Especial Sanidad Privada Nº28 Abril 2021 Director Juan Pablo Ramírez Redacción Cristina Cebrián Gema Maldonado Hortensia Mateo Pablo Malo Victoria Guillén Ana González-Besada Relaciones Institucionales María Vargas Maquetación Ana Macarro Marketing editorial María Romano Dirección General Luis A. de Haro

16. ASEGURAMIENTO SANITARIO

18.

EDITORIAL !"#$%#"$"&&'()#*"#+$%,%#-./ %#$%#0%&1)%&'()2#1)#-')'34"5'6 *"#789'463: OPINIÓN !5;#<"5)%)*6#-1=%5,%

6. PARTIDA PRESUPUESTOS

>1%456#*"#&%*%#&')&6#"3+%?6$"3# %1@")4%5A%)#$%#+%54'*%#*"# +5"31+1"3463#*"*'&%*%#%#3%)'*%*

ENTREVISTA -%54%#B'$$%)1"0%#C<1)*%&'()#.!.DE

10.

MANIFIESTO F%#G36&'%&'()#H3+%?6$%#+%5%# $%#>%$'*%*#3"#%*I'"5"#%$#-%)'J"346

12. 14.

ENSAYOS CLÍNICOS -D!#5"%J5@%#31#%+1"34%#+65#$% ')0"34'=%&'()

correo@isanidad.com

SIEMENS HEALTHINEERS D'"@")3#K"%$4I')""53#*"34%&%#"$# +%+"$#*"#$%#')4"$'=")&'%#%54'J&'%$

Edita Puesta en Mercado, SL Demóstones, 5 28032 Las Rozas. Madrid

H$# %3"=15%@'")46# 3%)'4%5'6# +5'0%*6# %I655%#I%34%#L;MNO#"1563#+65#+%&'")4"# %$#%?6 GASTO SANITARIO H$#=%346#3%)'4%5'6#+5'0%*6#")#H3+%?%# 3"#3'4P%#+65#")&'@%#*"#$%#@"*'%# *"#$%#Q>!H

20.

INTELIGENCIA ARTIFICIAL R"$"@"*'&')%2#.)4"$'=")&'%#G54'J&'%$# S#T'=#!%4%

24.

HOSPITALES E INDUSTRIA K63+'4%$"3#"#')*1345'%#&6$%U65%)# ")#H3+%?%#")#@V3#*"#LWX#")3%S63# &$A)'&63

26.

NOVO NORDISK Y606# Y65*'3Z# I%# +1"346# ")# @%5&I%# ")#H3+%?%#MN#")3%S63#&6)#L;[W\# +%&'")4"3

Comunicación responsable, emocional y perceptiva en Sanidad

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r. Fernando Mugarza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

Abril 2021. Sanidad Privada · www.isanidad.com · Página 5

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`.+-(R@+),+>(#)%/$4%-5%(4%(L.-F 4+,$0-( HKHA>( 1.%( E+( ,)$5$,+4'( *+( 8$-+,,$0-( #'*C5$,+;6

B2.)% =/.+8.C% D;.#% 6+,62"#*.#% $"&% '.)(E"#*,% "#*F)%.6,-.$.#%6,+%"&%GHI%$"%&,#%")82"#*.$,#J

6%'+.+&+-7( !/5%(%/5.4$'>(1.%(/%()%+*$&+(#')(/%?.-4'(+T'(,'-/%,.F 5$3'>(E+(+."%-5+4'(*+(".%/5)+(E+/5+(*'/(_6[aa(%-,.%/F 5+4'/6(8D'-(%/5+($-3%/5$?+,$0-(-'/(+/%?.)+"'/(5%-%)( .-'/(4+5'/(+(-$3%*(?*'@+*(2(E%"'/(4+4'(.-(#+/'("M/( #+)+(5%-%)(4+5'/(+(-$3%*(4%(,'".-$4+4%/(+.50-'"+/;>( E+(%:#*$,+4'(I'/+(KC+&>(4$)%,5')+(?%-%)+*(4%(A$?"+( 9&"/,:+0;%"<=(,/.(."%,"9)>(?(@"9,*$%)'(". K'/6(R/$"$/"'>(E+(/%T+*+4'(1.%(%*(Yb^(4%(*+(#'@*+F '(;D/E,"/,./*("F$%"%&"GHIJK".%"%)>(?+&%)"*+,)/ ,$0-( %-,.%/5+4+( /'*'( 5%-C+( ,'@%)5.)+( #S@*$,+( 2( .-( M,(,*/ \c^(,'-5+@+(,'-(+"@+/(,'@%)5.)+/6(7+/(%-,.%/5+/(/%( E+-()%+*$&+4'(+(.-([Y>d^(4%(E'"@)%/(2(.-(_\>]^(4%( ".=%)%/(%-5)%(%*(d_(4%("+)&'(2(%*(Y(4%("+2'(4%(dadc6 %-,.%/5+4'/(#$%-/+(1.%(*+(/+-$4+4(-'(%/5M(+4%,.+4+F "%-5%(O-+-,$+4+6(I%/#%,5'(+*(#)$-,$#$'(.-'(4%*(<+F 8%)$&'(.+)".%"&("%,*$%)'( -$O%/5'>(*+(+/$/5%-,$+(4%(,+*$4+4>(/%(,'-/$4%)+(%/%-,$+*( K%(*'/()%/.*5+4'/(/%(%:5)+%(*+(3+*')+,$0-(4%(*'/(./.+F #+)+( %*( ]c>d^( 4%( *+( #'@*+,$0-( %( $"#')5+-5%( #+)+( %*( )$'/( 5+-5'( 4%( *+( /+-$4+4( #S@*$,+( WY>ZZX( ,'"'( 4%( *+( c[>b^6(A$-(%"@+)?'>(/'*'(,.+5)'(4%(,+4+(4$%&(%/5M-( /+-$4+4( #)$3+4+( WY>YZX>( 1.%( E+( +."%-5+4'( )%/#%,F ".2(/+5$/B%,E'/(,'-(*+(,+*$4+4(4%*(/$/5%"+(/+-$5+)$'6 5'( +*( dada( WY>\bX6( 87+( /+-$4+4( #)$3+4+( /%( %/5M( ,'-F /'*$4+-4'( /',$+*"%-5%>( E+( %/5+4'( #)%/%-5%( %-( *'/( !-( ,.+-5'( +( *'/( #)$-,$#$'/( d( 2( \( 4%*( <+-$O%/5'>( "'"%-5'/( "M/( 4.)'/( 4%( *+( #+-4%"$+( 2( E+( +2.4+F .-+( /+-$4+4( %-B',+4+( %-( %*( #+,$%-5%( 2( ,'-( *'/( #)'F 4'( +( )%/'*3%)( %*( d_^( 4%( ,+/'/( 4%( *+( #'@*+,$0-( +B%,F B%/$'-+*%/>( *'/( 4+5'/( )%f%=+-( 1.%( #+)+( ',E'( 4%( ,+4+( 5+4+( #')( %*( D'3$4Fcb;>( E+( +/%?.)+4'( <+)5+( e$**+F 4$%&( %/#+T'*%/( %/( ,*+3%( %( $"#')5+-5%( $"#.*/+)( *+( -.%3+>( 4$)%,5')+( ?%-%)+*( 4%( *+( L.-4+,$0-( HKHA6 #+)5$,$#+,$0-( 4%( *'/( #+,$%-5%/6( 87+( #)M,5$,+( 5'5+F *$4+4( 4%( *+( /',$%4+4( %/#+T'*+( 1.$%)%( 1.%( *'/( #+F A%?S-(E+(4%/5+,+4'>(*+(%-,.%/5+(".%/5)+(1.%(,.+5)'( ,$%-5%/( 5%-?+-( 3'&;>( E+( /.@)+2+4'( <+)5+( e$**+F 4%( ,+4+( ,$-,'( %/#+T'*%/( WZ]^X>( $-4%#%-4$%-5%"%-F -.%3+6( R/$"$/"'>( ,+/$( %*( caa^( 4%( *'/( %/#+T'*%/( 5%(4%(/.(,'@%)5.)+(/+-$5+)$+>(%*%?$)C+(*+(/+-$4+4(,'"'( ,'-/$4%)+(-%,%/+)$'(5%-%)(%-(,.%-5+(*+/(-%,%/$4+4%/( #+)5$4+( #)$')$5+)$+( #+)+( 4'5+)*+( 4%( "M/( )%,.)/'/( %-( 2( %:#%,5+5$3+/( 4%( *'/( #)'B%/$'-+*%/( /+-$5+)$'/>( 1.%( *'/(#)%/.#.%/5'/(4%*(!/5+4'6(R4%"M/>(%*(Zc>_^(4%(*'/( /%( E+-( ,'-3%)5$4'( %-( *'/( 1.%( 8/'/5$%-%-( %*( /$/5%"+;6

Cuatro de cada cinco e la partida de presupues

Página 6 · www.isanidad.com · Sanidad Privada. Abril 2021

/$,'(2(.-(]>c^(#$%-/+(1.%(%/(-%,%/+)$'6(A$-(%"@+)?'>( .-(]\>Y^(4%(*'/(%/#+T'*%/(,)%%-(1.%(E+2(&'-+/(4'-4%( -'(/%(,.@)%-(5'4'/(*'/(/%)3$,$'/(/+-$5+)$'/(#')($?.+*6( !*(<+-$O%/5'(HKHA(5+"@$9-(4%4$,+(/%-4'/(+#+)5+4'/( +(*+(%O,$%-,$+(2(*+(5)+-/#+)%-,$+6(!*(b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

españoles aumentarían stos dedicada a sanidad

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

M2"5"%$"%8.$.%$("?%"#6.L,&"#%8+"")% /.#*.)*"%,%72-%)"8"#.+(,%"&%$"#.++,&&,%"% (76&.)*.8(<)%$"%()),5.8(,)"#%8(")*0E8.#%6.+.% 7"N,+.+%&.%8.&($.$%$"%&.%.#(#*")8(.% #.)(*.+(. !-(,.+-5'(+*(+#+)5+4'()%B%)%-5%(+(*+(4$?$5+*$&+,$0-(2( 5%,-'*'?C+>(%*(b_>Z^(4%(*+(#'@*+,$0-(,'-/$4%)+(-%,%F /+)$'($-,')#')+)(*+/(S*5$"+/($--'3+,$'-%/(5%,-'*0?$F ,+/( 2( 4$?$5+*%/( %-( *'/( #)',%/'/( 4%( /+*.46( g%/5$0-( 4%( ,$5+/(Wba>_^X(2(+,,%/'(4%*("94$,'(+(*'/(4+5'/(Wbd>_^X( /'-( *'/( 4'/( +/#%,5'/( 1.%( "M/( "%=')+)C+-( *'/( %/#+F T'*%/6( L$-+*"%-5%>( <+)5+( e$**+-.%3+( E+( 4%/5+,+4'( *+($"#')5+-,$+(4%(*'/(4+5'/(4%(%/5+(%-,.%/5+(#+)+(%*( <+-$O%/5'6(8D)%C+"'/(1.%(%*(%-B'1.%(%)+(+4%,.+4'( 2( #+)+( -'/'5)'/( %)+( B.-4+"%-5+*( 5%-%)( %*( +#'2'( -'( /'*'(4%(')?+-$&+,$'-%/(%($-/5$5.,$'-%/(/$-'(4%(*+(#'F @*+,$0-(%-(?%-%)+*;6(V')(/.(#+)5%>(h-?%*(4%(i%-$5'>(/%F ,)%5+)$'( ?%-%)+*( 4%( *+( L.-4+,$0-( HKHA>( E+( /%T+*+4'( 1.%( *+( #+-4%"$+( E+( +2.4+4'( +( 1.%( *+( ,'*+@')+,$0-( #S@*$,'F#)$3+4+(B.%/%("M/(3+*')+4+(#')(*+(#'@*+,$0-6

'.+*.%K(&&.)2"5.C%D;.%6+F8*(8.%*,*.&($.$%$"%&.% 6,/&.8(<)% "#6.L,&.% $"E")$"% &.% 8,&./,+.8(<)% ")*+"%&.%#.)($.$%$"%.7/.#%*(*2&.+($.$"#J 87+/('#$-$'-%/(4%(*+(/',$%4+4(%/#+T'*+(+,%),+(4%(*'/( I%/#%,5'( +( *+( %1.$4+4>( '5)'( 4%( *'/( #.-5'/( 4%*( <+F -$O%/5'>(,+/$(*+(5'5+*$4+4(4%(%/#+T'*%/(3%(%/%-,$+*(*+( $?.+*4+4(4%(,+#+,$4+4(4%(+,,%/'(+(+/$/5%-,$+(/+-$5+)$+( 4%(,+*$4+46(D'-,)%5+"%-5%>(.-(]b>a^(*'(,'-/$4%)+(@MF

ca(#)$-,$#$'/(4%*(<+-$O%/5'(8V')(.-+("%=')(/+-$4+48>( ,'-O)"+-(*+(-%,%/$4+4(4%(,'-5%"#*+)(5'4'/(%**'/(#+)+( 4$/#'-%)(4%(.-(/$/5%"+(/+-$5+)$'(+4+#5+4'(+(*'/()%5'/( 2( -%,%/$4+4%/( 4%( #)%/%-5%( 2( B.5.)'( ,'-( #'),%-5+=%/( 1.%(/.#%)+-(%*(Z_^(%-(%**'/;>(,'-,*.2%-(4%/4%(HKHA6 Abril 2021. Sanidad Privada · www.isanidad.com · Página 7

Marta Villanueva (Fundación IDIS): Necesitamos reformar entre todos un sistema sanitario anclado en el tiempo ,'-5%"#*+( 4$%&( #)$-,$#$'/( ,*+3%( 1.%( +( /.( 3%&( %:#'F -%-( 4$%&( "'5$3'/( 4%( )%f%:$0-( 2( 4%( +@')4+=%( .)?%-F 5%>(,'-(%*(O-(S*5$"'(4%(,'-/%?.$)(4$/#'-%)(%-(!/#+F T+(4%(*+("%=')(/+-$4+46(j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e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f%:$0-(2(4%@+5%(,'-/'*$4+F "%=')(A+-$4+4(#+)+(5'4'/(%/(#')(*'(1.%("%4$+-5%(%*( 4'(%-(.-(<+-$O%/5'>(%-(.-+(4%,*+)+,$0-(#S@*$,+(1.%( /."+5')$'(4%(%/B.%)&'/(2(".*5$#*$,+,$0-(4%(3'*.-5+F

Página 8 · www.isanidad.com · Sanidad Privada. Abril 2021

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`3a' Q!b`XV3cdR'-$'*#'8"-'-*',-.6&1',#$/6#1/&'2P)*/.&',-' (#' 7/,6&' %-,)&1%#%&' -$' #*9"$&,' +&+-$6&,' 5' -$' -*' 8"-'*#'.&&2-1#./0$'%-*',/,6-+#'21/7#%&'(#',/%&'<"$3 %#+-$6#*4' .*#7-4' 2#1#' 8"-' *#,' .&$,-."-$./#,' $&' (#3 5#$',/%&'2-&1-,'%-'*&'8"-'5#'%-'2&1',:'(#$',/%&>'?#' 2"-,6#'#'%/,2&,/./0$'%-'6&%&,'*&,'1-."1,&,'-,61".6"3 1#*-,4' 21&<-,/&$#*-,4' 6-.$&*09/.&,4' -6.>>>' (#$' 2-1+/3 6/%&' #,"+/1' *#' /$9-$6-' 21-,/0$' #,/,6-$./#*' %-*' ,/,6-3 +#4'-,2-./#*+-$6-'-$'*&,'+&+-$6&,'+@,'@*9/%&,4'*&' 8"-' (#' %#%&' .&+&' 1-,"*6#$6-' 8"-' *#' +&16#*/%#%' $&' (#5#'/%&'+@,'#**@'%-'*&'8"-'%-,91#./#%#+-$6-'(#'/%&>' E&1'&61&'*#%&4'-,'%-'%-,6#.#1'-*'-$&1+-'-,<"-1=&'1-#3 */=#%&' 2&1' *&,' *#)&1#6&1/&,' <#1+#.B"6/.&,' 5' *&,' /$3 7-,6/9#%&1-,' #' *#' (&1#' %-' .&$,-9"/1' "$' 1-+-%/&' -F3 .#='%-'21-7-$./0$'21/+#1/#'-$'6/-+2&'1B.&1%'.&+&' -,'*#'7#."$#'5'-$'21&%"./1*&'5'%/,61/)"/1*&'-$'+#,#4' #,:' .&+&' -*' -+2-;&' 8"-' -,6@$' 2&$/-$%&' -$' %-,#3 11&**#1' +-%/.#+-$6&,' -,2-.:F.&,' <1-$6-' #' -,6-' .&+3 2*-A&' 7/1",>' H$' -,6-' +/,+&' ,-$6/%&' #19"+-$6#*4' *#' /$%",61/#' %-' 6-.$&*&9:#' ,#$/6#1/#' 6#+)/B$' (#' (-.(&' "$' -,<"-1=&' -$&1+-' .&$' *#' 2"-,6#' #' %/,2&,/./0$' %-' #2#1#6#A-'%/1-.6#+-$6-'/$7&*".1#%&'-$'-*'61#6#+/-$3 6&' %-' *&,' 2#./-$6-,' /$<-.6#%&,' 2&1' -,6-' .&1&$#7/1",>' E&1' 6&%&' -**&4' %-' $"-7&' ,-' 2&$-' %-' +#$/F-,6&' 8"-' ,/-+21-4'5'-,2-./#*+-$6-'-$'+&+-$6&,'%-'91#7-'-,3 61B,' ,#$/6#1/&' .&+&' -*' 7/7/%&' *#' .&*#)&1#./0$' %-' 6&3 %&,' -,' /+21-,./$%/)*->' N-+&,' %-' 2-$,#1' %-,%-' -*' 21-,-$6-'-$'"$#',#$/%#%',/$'#2-**/%&,4'-$'"$#',#$/3

%#%'.&*#)&1#6/7#'5'-F./-$6-'8"-'6-$9#'#*'21&<-,/&$#*' 5' #*' 2#./-$6-' .&+&' ,",' 21/$./2#*-,' 21&6#9&$/,6#,>

!"#$%&'()&$&'&*+#,'&-'./-+,#' $&'0#'1&2/,'*#-%$#$3 !;4(2$%&#'#$)<&'),$#1+#$=)*0>#1+2$)$)')%+),$#-$ 101+#()$ 1)*0+),02$ )$ -)1$ *#/#10')'#1$ <$ -21$ #*2,(#1$ ,#+21$?&#$#1+@*$<)$)%),#/0#*'2: E1-./,#+-$6-',"+#$%&'7&*"$6#%-,'5'#%(-,/&$-,'8"-' -,'*&'8"-'-$'-,6-'+&+-$6&'-,6#+&,'21&."1#$%&e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bril 2021. Sanidad Privada · www.isanidad.com · Página 9

La Asociación Española para la Calidad se adhiere al Manifiesto “Por una Mejor Sanidad” impulsado desde la Fundación IDIS

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

=5"&(),%R+(*,9%$(+"8*,+%S")"+.&%$"%=OT%U.% $"#*.8.$,%D&.%(76,+*.)8(.%$"%6+,7,5"+%2).% P.)($.$%12"%.62"#*"%6,+%&.%8.&($.$% -%&.%"48"&")8(.

&,#%+"82+#,#%$(#6,)(/&"#%-%8,)%&.%8,,6"+.8(<)% $"%*,$,#%&,#%.S")*"#J

8R4%"M/>(%/(-%,%/+)$'()%+*$&+)(.-+(?%/5$0-(+4%,.+4+(4%( *'/("$/"'/(,'"'(?+)+-5C+(4%(,+*$4+4(+/$/5%-,$+*(4%-F 5)'(4%(.-(/$/5%"+(')$%-5+4'(+(4+)()%/#.%/5+(+4%,.+4+( +(*+/(-%,%/$4+4%/(4%(*'/(#+,$%-5%/('B)%,$%-4'(*'/("%F =')%/()%/.*5+4'/(/+-$5+)$'/(2(4%(/+*.4(#'/$@*%/(2(4'-4%( *+(,'')4$-+,$0-(#+)+(*+()%/'*.,$0-(4%(*'/(#)'@*%"+/( "M/(.)?%-5%/(%($"#')5+-5%/(/%+-(*+(,*+3%8>(E+(+T+4$4'6

!*( 4$)%,5')( ?%-%)+*( 4%( *+( R/',$+,$0-( !/#+T'*+( #+)+( *+( D+*$4+4>( R3%*$-'( i)$5'>( E+( 4%/5+,+4'( 8*+( $"#')F 5+-,$+(4%(#)'"'3%)(.-+(A+-$4+4(1.%(+#.%/5%(#')(*+( ,+*$4+4( 2( *+( %:,%*%-,$+>( ,'-( %*( '@=%5$3'( 4%( @)$-4+)( .-+(+/$/5%-,$+(/+-$5+)$+(1.%(+/%?.)%(*+(%O,+,$+(4%(*'/( #)',%/'/>(,%-5)+4+(%-(*'/(#)'B%/$'-+*%/(2(#+,$%-5%/86 R(%/5%(<+-$O%/5'(/%(E+-(+4E%)$4'(4%,%-+/(4%(')?+-$&+F ,$'-%/6(R *?.-+/(4%(%**+/(5+-()%*%3+-5%/(,'"'(L%-$->(L+)F V')( /.( #+)5%>( *+( 4$)%,5')+( ?%-%)+*( 4%( *+( L.-4+,$0-( "+$-4./5)$+>(V)'V+5$%-/(D'-/%='/(?%-%)+*%/(4%(K%-5$/F HKHA>( <+)5+( e$**+-.%3+>( E+( )%,')4+4'( 1.%( %*( '@F 5+/>(<94$,'/('(L+)"+,9.5$,'/>(R-%B#(2('5)'/(".,E'/6 Página 10 · www.isanidad.com · Sanidad Privada. Mayo 2021

]

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

Siemens Healthineer de la inteligencia arti mejores resultados s H,6-' (#' ,/%&' "$&' %-' *&,' 6-+#,' 61#6#%&,' %"1#$3 6-' *#' P*6/+#' 1-"$/0$' %-*' !&+/6B' %-' X$$&7#3 ./0$' %-' *#' W"$%#./0$' X$,6/6"6&' 2#1#' -*' V-,#11&3 **&' -' X$6-91#./0$' %-' *#' D#$/%#%' QW"$%#./0$' XVXDR> H$' .&$.1-6&4' f-,P,' E1/-6&' `#1#4' %/1-.6&1' %-' %/#93 $0,6/.&' 2&1' /+#9-$' 5' 6-1#2/#4' 5' V#7/%' g*7#1-=4' %/3 1-.6&1' %-' ,#*"%' %/9/6#*4' 21-,-$6#1&$' *&,' )-$-F./&,' %-' *#' /$6-*/9-$./#' #16/F./#*' 2#1#' 8"-' *&,' +B%/.&,' 2"-%#$' 6-$-1' "$#' 7/,/0$' .&+2*-6#' 5' 2-1,&$#*/3 =#%#' %-' *&,' 21&.-,&,' 8"-' #<-.6#$' #' ,",' 2#./-$6-,>'

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ágina 12 · www.isanidad.com · Sanidad Privada. Abril 2021

rs destaca el papel ificial para conseguir sanitarios y de salud 6-' %-*' #)&1%#A-' %-' .#%#' 2#./-$6-4' %-,%-' -*' %/#9$0,3 6/.&'%-'*#'-$<-1+-%#%'(#,6#'-*'F$#*'%-*'61#6#+/-$6&> H$' *#' ,-,/0$' ,-' /$%/.0' 8"-' "$' h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

>-'?@A'$&'0/*'(#.%&-+&*'$&.0#,#' B)&'0#'%-;/,1#.%<-'-&.&*#,%#'(#,#'*)'#+&-.%<-' -/'&*+#C#'$%*(/-%C0&'.)#-$/'&,#'-&.&*#,%/ g$9-*' %-' i-$/6&' 5' ^#16#' `/**#$"-7#4' ,-.1-6#1/&' 9-3 $-1#*'5'%/1-.6&1#'9-$-1#*'%-'*#'W"$%#./0$'XVXD4'1-,3 2-.6/7#+-$6-4' /$%/.#1&$' 8"-' )/9' %#6#' &' /$6-*/9-$./#' #16/F./#*' QX]R' -1#$' 6B1+/$&,' 8"-' $&' .&$&.:#+&,' (#.-' #;&,>' D/$' -+)#19&4' -*' !&7/%3cd' (#' &)*/9#%&' #' .#+)/#1' 21&.-,&,' 5' 21&.-%/+/-$6&,' 8"-' (#$' 21&3 7&.#%&' "$#' #.-*-1#./0$' -$' *#' /$$&7#./0$' %/9/6#*>' OH*' ,-.6&1' ,#*"%' -,' "$&' -$' *&,' 8"-' +@,' #7#$.-,' (#' -C2-1/+-$6#%&' 5' ,/9"-' (#./B$%&*&>' H,' <"$%#+-$3 6#*' *#' #.6"#*/=#./0$' .&$,6#$6-' #' 61#7B,' %-' 1-"$/&$-,' .&+&' -,6#' 2#1#' .&$&.-1' 6&%#,' *#,' $&7-%#%-,' 5' *#,' 2&,/)/*/%#%-,' %-' /$6-91#1*#,' -$' *#' 21@.6/.#' .*:$/.#S> Mayo 2021. Sanidad Privada · www.isanidad.com · Página 13

MSD reafirma su apuesta por la investigación poniendo en valor el papel crucial de los ensayos clínicos

#'.&+2#;:#'^DV'#,2/1#'#'.&$7-16/1,-'-$'*#' 21/$./2#*'-+21-,#')/&<#1+#.B"6/.#'%-'/$7-,6/9#./0$4' #'+-A&1#1'*#',#*"%'5'-*')/-$-,6#1'%-'*#,'2-1,&$#,'5'*&,' #$/+#*-,'5'#'#+2*/#1'-*'#..-,&'#',",'+-%/.#+-$6&,'5' 7#."$#,>'E#1#'-**&4'-$'-*'+#1.&'%-*'V:#'X$6-1$#./&$#*' %-*'H$,#5&'!*:$/.&4'8"-',-'.-*-)1#'-*'aK'%-'+#5&4'^DV' .&$6/$P#'.&$',"'#2"-,6#'2&1'*#'/$7-,6/9#./0$'2&$/-$3 %&' -$' 7#*&1' -*' 2#2-*' .1"./#*' %-' *&,' -$,#5&,' .*:$/.&,' 2#1#'&<1-.-1'$"-7#,'&2./&$-,'6-1#2B"6/.#,'-F.#.-,'5' ,-9"1#,'#'*&,'2#./-$6-,'-$'-*'+-$&1'6/-+2&'2&,/)*->

H,6-' .&+21&+/,&' ,-' +#$6/-$-' F1+-' 5' ,-' ,"2-1#' #;&' 61#,' #;&4' .&+&' .&11&)&1#$' *#,' ./<1#,' 5#' 8"-4' -$' aKaK4' ^DV' %-,6/$0' cj>kKK' +/**&$-,' %-' %0*#1-,' #' 21&5-.6&,' %-' XlV>' ],:4' ^DV' ,-' .&$7/-16-' -$' "$#' %-' *#,' -+21-,#,' *:%-1-,' -$' $P+-1&' %-' -$,#5&,' .*:3 $/.&,'-$'+#1.(#>'H$'*#'+/,+#'*:$-#4'^DV'-$'H,2#3 ;#'/$7/16/0'Mj'+/**&$-,'%-'-"1&,'-$'XlVl/'-$'aKcd>' ],/+/,+&4' .#)-' ,-;#*#14' 8"-' *#' ,"),/%/#1/#' -,2#;&3 *#' 8"-' &."2#' -*' 21/+-1' 2"-,6&' -"1&2-&' -$' $P+-1&' %-' -$,#5&,' .*:$/.&,' 5' 2#16/./2#' -$' +@,' %-*' MKL' %-' *&,' -$,#5&,' .*:$/.&,' %-' *#' -+21-,#' #' $/7-*' 9*&)#*>

D4E'./-+%-=#'./-'*)'#()&*+#'(/,'0#'%-F&*+%8#G .%<-'(/-%&-$/'&-'F#0/,'&0'(#(&0'.,).%#0'$&'0/*' ?&"1%-,' ?02-=3i1#7&4' %/1-.6&1#' -A-."6/7#' %-' b2-3 &-*#H/*'.0:-%./*'(#,#'/;,&.&,'-)&F#*'/(.%/-&*' 1#./&$-,'!*:$/.#,'-$'^DV4'#F1+#m'O-$'$"-,61#'.&+3 +&,#(I)+%.#*'&9.#.&*'H'*&8),#* 2#;:#'61#)#A#+&,'%/#1/#+-$6-'2#1#'61#6#1'%-'%#1'1-,3 Página 14 · www.isanidad.com · Sanidad Privada. Mayo 2021

2"-,6#' #' #*9"$&,' %-' *&,' +#5&1-,' %-,#<:&,' %-' ,#*"%' -C/,6-$6-,>'_&%&'*&'8"-'(#.-+&,4'%-$61&'5'<"-1#'%-*' *#)&1#6&1/&4',-')#,#'-$'$"-,61&'#21-./&'21&<"$%&'2&1' *#'7/%#>'U'*&,'-$,#5&,'.*:$/.&,'6/-$-$'"$'2#2-*'.*#7-' -$'-,6-',-$6/%&4'#.-*-1#$%&'*#'**-9#%#'%-'$"-7&,'61#3 6#+/-$6&,'2#1#'.")1/1'*#,'$-.-,/%#%-,'%-'*&,'2#./-$3 6-,' 5' 9-$-1#$%&' "$' $"-7&' .&$&./+/-$6&' ./-$6:F.&' 8"-' 2"-%#' ,-1' #2*/.#%&' -$' <"6"1#,' /$7-,6/9#./&$-,S>'

1#2B"6/.#,'5'*#,'`#."$#,'<1-$6-'#*'!&7/%3cd>'H,6#'/$/3 ./#6/7#'-,6#'*/%-1#%#'2&1'*&,'X$,6/6"6&,'T#./&$#*-,'%-' *#'D#*"%'%-'H,6#%&,'I$/%&,'QTXNR>'H$'-,6#'/$/./#6/7#' 6#+)/B$'2#16/./2#$'&61#,'/$,6/6"./&$-,'.&+&'*#']9-$3 ./#'H"1&2-#'%-*'^-%/.#+-$6&'QH^]R'5'&61#,'.&+2#3 ;:#,'<#1+#.B"6/.#,>'E&1'P*6/+&4'^DV'(#'#*.#$=#%&'"$' #."-1%&'(/,601/.&'.&$'f&($,&$'['f&($,&$'2#1#'#9/*/3 =#1'*#'21&%"../0$'%-',"'7#."$#'.&$61#'-*'!&7/%3cd>

J-'K@K@L'D4E'$&*+%-<'MNOP@@'1%00/-&*' $&'$<0#,&*'#'(,/H&.+/*'$&'QREO'S*%1%*1/L' &-'J*(#T#'%-F%,+%<'UN'1%00/-&*'$&'&),/*' &-'QRER%'&-'K@MV

D02*#,21$#*$EFG$#*$0*(&*22*/2-2HI) D/$' -+)#19&4' *#' #2"-,6#' %-' ^DV' 2&1' *#' XlV' $&' ,&*&' ,-' */+/6#' #' 7#."$#,' 5' -$<-1+-%#3 %-,' /$<-../&,#,4' ,/$&' 8"-' 7#' +".(&' +@,' #**@>'

],:4' *&,' -$,#5&,' .*:$/.&,' ,&$' -*' +-A&1' -A-+2*&' %-' .&*#)&1#./0$' 2P)*/.&321/7#%#>' I$#' +"-,61#' .*#3 1#' %-' .0+&' *#' "$/0$' 5' -*' 61#)#A&' .&+P$' %-' *&,' %/3 <-1-$6-,' #.6&1-,' /+2*/.#%&,' 2"-%-' 9-$-1#1' 1-3 *#./&$-,' ,/$B19/.#,' -$' )-$-F./&' %-' *#' ,&./-%#%>

?#'.&+2#;:#'6/-$-'-*'+#5&1'21&91#+#'%-'/$7-,6/9#./0$' .*:$/.#'-$'/$+"$&&$.&*&9:#'%-'*#'/$%",61/#4'.&$'+@,'%-' c>jKK'-$,#5&,'8"-'-7#*P#$'2-+)1&*/="+#)'-$'"$#'#+3 2*/#'7#1/-%#%'%-'.@$.-1-,'5'.&$6-C6&,'%-'61#6#+/-$6&>

7#'./1(#T:#'+%&-&'&0'1#H/,'(,/8,#1#'$&'%-G ],/+/,+&4'-$'"$'#;&'+#1.#%&'2&1'*#'2#$%-+/#'21&7&3 F&*+%8#.%<-' .0:-%.#' &-' %-1)-//-./0/8:#' $&' 0#' .#%#'2&1'-*'!&7/%3cd4'^DV',-'(#'.&+21&+-6/%&'#'"$/1' %-$)*+,%#L'./-'1[*'$&'MON@@'&-*#H/*'B)&'&F#G <"-1=#,'-'/$7-,6/9#1'2#1#'&<1-.-1'"$#'1-,2"-,6#'-F.#=' 0=#-'(&1C,/0%Y)1#C' <1-$6-'#*'7/1",>'V-'-,6-'+&%&4'*#'.&+2#;:#'(#'1-<&1=#3 %&',"'*#)&1'/$7-,6/9#%&1#'5'.-$61#%&',",'-,<"-1=&,'-$' #*.#$=#1'"$'#."-1%&'2#1#'-*'%-,#11&**&'%-'"$'.#$%/%#3 6&'6-1#2B"6/.&>'H$'.&$.1-6&4'6/-$-'-$'<#,-'%-'/$7-,6/3 9#./0$'^n3JJMa'Q+&*$"2/1#7/1R'8"-'.&$6/$P#'.&$',"' 21&91#+#'%-'%-,#11&**&'.*:$/.&'-$'2#./-$6-,'#+)"*#3 6&1/&,>'E&1'&61&'*#%&4'^DV',-'(#',"+#%&'#'%/<-1-$6-,' /$,6/6"./&$-,'2P)*/.#,'5'21/7#%#,'.&+&'*#'W"$%#./0$' i/**'5'^-*/$%#'Y#6-,'5'-*'.&$,&1./&'%-'.&+2#;:#,'/$3 $&7#%&1#,'8"-'-,6@$'61#)#A#$%&'2#1#'-$.&$61#1'1-,3 2"-,6#,'6-1#2B"6/.#,'5'21-7-$6/7#,'<1-$6-'#*'!&7/%3cd>

V-'(-.(&4'^DV'-,'2/&$-1#'-$'-,6#'@1-#'.&$,/9"/-$3 %&' /+2&16#$6-,' (/6&,' (#,6#' *#' <-.(#>' H$' aKcc' /$/3 ./0' -*' 21/+-1' -$,#5&' .*:$/.&' .&$' 2-+)1&*/="+#)' 5' -$' aKcd' (#):#' +@,' %-' c>cKK' -$,#5&,' .*:$/.&,' #' $/7-*' +"$%/#*' .&$' 2-+)1&*/="+#)' 5' ,-' 2")*/.#3 1&$' +@,' %-' kh' #16:."*&,' ./-$6:F.&,' -$' 1-7/,6#,' %-' #*6&' /+2#.6&4' .&+&' ?#$.-64' f]^]4' ]$$"#*,' &<' b$3 .&*&954' &' f&"1$#*' !*/$/.#*' b$.&*&954' -$61-' &61#,>'

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`4'*#'X$/./#6/7#'2#1#'].-*-1#1'*#,'X$6-17-$./&$-,'_-3 2#1#' *#' ,#*"%' %-' *#,' 2-1,&$#,S4' 1-,#*6#' ?02-=3i1#7&> Mayo 2021. Sanidad Privada · www.isanidad.com · Página 15

El aseguramiento sanitario privado ahorra hasta 1.368 euros por paciente al año

spaña cuenta con 9,2 millones de asegurados, sin contar con los mutualistas, que contribuyen a la “descarga y ahorro del sistema nacional de salud”. Concretamente, se estima que el ahorro producido por un paciente que use exclusivamente el sistema privado es de 1.368 euros. En el caso de que el ciudadano cubierto por una póliza privada haga un uso mixto y consuma recursos públicos y privados, se calcula un ahorro a la sanidad pública de 506 euros. Así, se estima que el aseguramiento privado ahorra entre 4.689 y 12.676 millones de euros al SNS, según los daPágina 16 · www.isanidad.com · Sanidad Privada. Mayo 2021

tos del informe de la Fundación IDIS “Sanidad privada, aportando valor: Análisis de la situación 2021“.

Se estima que el aseguramiento privado ahorra entre 4.689 y 12.676 millones de euros al SNS Las últimas cifras publicadas por el Ministerio de Sanidad indican que el gasto sanitario público per cápita se situó en 1.593 euros en 2019. En este sentido, se estima que el gasto sanitario per cápita en 2020 ha sido de 1.620 euros, 27 euros por encima del gasto per cápi-

ta público en 2019. Respecto al gasto sanitario privado per cápita se estima que ha evolucionado de 601 euros en 2019 a 619 en 2020. De ellos, 464 euros corresponden a gasto de bolsillo y 156 a gasto en aseguramiento. El informe indica que País Vasco, Asturias y Cataluña son las comunidades autónomas que registraron mayor gasto sanitario per cápita en 2019. Por el contrario, Andalucía, Castilla La Mancha y Canarias son las que tuvieron un menor gasto sanitario per cápita.

País Vasco, Asturias y Cataluña son las comunidades autónomas que registraron mayor gasto sanitario per cápita en 2019 Si se realiza una estimación de la evolución de los datos para 2020, el País Vasco seguiría siendo la comunidad autónoma con un mayor gasto sanitario per cápita, seguida de Asturias y Navarra. Por otro lado, el informe recoge que Andalucía, Canarias y Castilla La Mancha seguirían siendo las comunidades con un menor gasto sanitario per cápita.

Asimismo, el informe asegura que “el sector asegurador continúa registrando incrementos significativos”. En 2020 se han alcanzado los 11 millones de asegurados, lo que supone un incremento del CAGR al 4,4% respecto al año anterior. Por tipología, el 77% de los asegurados corresponden a asistencia sanitaria, el 16% a mutualismo administrativo y el 7% restante a reembolso de gastos. Todas las provincias españolas han crecido en número de asegurados respecto al año anterior.

En 2020 se han alcanzado los 11 millones de asegurados y se han superado los 9.000 millones de euros en volumen de primas A nivel de volumen de primas, en 2020 han superado los 9.000 millones de euros. Esto supone un incremento del CAGR al 5,1% con respecto a 2019. Por tipología, el 73% corresponde a asistencia sanitaria, el 18% a mutualismo administrativo y el 9% a reembolso de gastos.

“Aquellas comunidades autónomas que tienen una Todas las comunidades autónomas superaron el mayor penetración del seguro privado, pueden tegasto sanitario presupuestado en 2019. En cuan- ner un menor gasto en provisión debido, en parto al gasto sanitario privado per cápita, se estima te, al ahorro que genera el aseguramiento privado”, que Madrid, Cataluña y País Vasco son las comu- subraya el informe. Respecto al mercado, el sector nidades autónomas que registraron los gastos más del seguro sanitario presenta un alto grado de conelevados en 2020. Por su parte, Extremadura, Mur- centración. Las 5 principales compañías represencia y Cantabria son las que menor gasto tuvieron. tan un 72% del mercado en volumen de primas.

Mayo 2021. Sanidad Privada · www.isanidad.com · Página 17

El gasto sanitario priva por encima de la

*' ,-.6&1' ,#$/6#1/&' 21/7#%&' 1-21-,-$6#' "$' -*-7#%&' 2-,&' -$' -*' ,-.6&1' 21&%".6/7&' -,2#;&*>' H*' 9#,6&' ,#$/6#1/&' -$' H,2#;#' ,-' ,/6P#' -$' -*' dL' %-*' EXi' -$' aKcd4' 7#*&1' +"5' ,/+/*#1' #*' 1-9/,61#%&' -$' *&,' P*6/+&,' #;&,>' ],:4' -*' 9#,6&' ,#$/6#1/&' 21/7#3 %&' 1-21-,-$6#' -*' ad4aL' %-*' 9#,6&' ,#$/6#1/&' 6&6#*4' 1-21-,-$6#$%&' +@,' %-*' adL' 2&1' 6-1.-1' #;&>' H,3 2#16-4' ,-9P$' %#6&,' %-' *#' b!VH4' .&$6/$P#' .&$' ,"' 2#;#' -,' "$&' %-' *&,' 2#:,-,' %&$%-' -*' 9#,6&' ,#$/6#3 6-$%-$./#' %-' .1-./+/-$6&' /$/./#%#' -$' aKcJ' (#,3 1/&' 21/7#%&' -,' +@,' -*-7#%&' Qad4aLR4' ,/6"@$%&3 6#'#*.#$=#1'*&,'od>jck'+/**&$-,'%-'-"1&,'-$'aKcd>' ,-' 2&1' -$./+#' %-' *#' +-%/#' %-' *#' b!VH' Qaj4jLR>' H*' 9#,6&' ,#$/6#1/&' 2P)*/.&' (#' -7&*"./&$#%&' #' "$#' H$' .&$.1-6&4' -*' 9#,6&' ,#$/6#1/&' -$' H,2#;#' .&$' 6#,#' %-' .1-./+/-$6&' #$"#*' .&+2"-,6&' Q!]YZR' 1-*#./0$' #*' EXi' ,-' -$."-$61#' K4d' 2"$6&,' 2&1' %-3 %-*'cL'%"1#$6-'*#'P*6/+#'%B.#%#>'!&$.1-6#+-$6-4' )#A&' %-' *#' +-%/#' b!VH' 5' h4d' 2"$6&,' 2&1' -$3 a' 2"$6&,' 2&1.-$6"#*-,' +-$&,' 8"-' -*' .1-./+/-$3 ./+#' %-' *#' +-%/#' b!VH' %-*' 9#,6&' ,#$/6#1/&' 6&' -C2-1/+-$6#%&' 2&1' -*' 9#,6&' ,#$/6#1/&' 21/7#%&>' 21/7#%&>' ],:' *&' 1-<*-A#$' *&,' %#6&,' %-*' /$<&1+-' %-' *#' W"$%#./0$' XVXD' OD#$/%#%' 21/7#%#4' #2&13 ]%-+@,4'-*'.1-./+/-$6&'%-*'9#,6&',#$/6#1/&'2P)*/.&' 6#$%&' 7#*&1m' ]$@*/,/,' %-' *#' ,/6"#./0$' aKacO> (#' ,/%&' O+-$&,' .&$,6#$6-S' 8"-' -*' 9#,6&' ,#$/6#1/&' 21/7#%&4'(#)/-$%&',"<1/%&'%&,'91#$%-,'1-61&.-,&,' J0'8#*+/'*#-%+#,%/'&-'J*(#T#'./-',&0#.%<-' -$' *&,' #;&,' aKca' 5' aKcj4' 2-1&' O1-."2-1#$%&' .*#3 #0'\Q]'*&'&-.)&-+,#'@LV'()-+/*'(/,'$&C#2/' 1#+-$6-' *&,' $/7-*-,' 21-7/&,' #' *#' .1/,/,' -.&$0+/3 $&'0#'1&$%#'^WEJ'H'?LV'()-+/*' .#S' 8"-' ,-' /$/./0' -$' aKcK' #' 2#16/1' %-' aKck3aKco>

(/,'&-.%1#'$&'0#'1&$%#'^WEJ' $&0'8#*+/'*#-%+#,%/'(,%F#$/

D-9P$' -*' ^/$/,6-1/&' %-' D#$/%#%4' -$' *#' H,6#%:,6/.#' %-*' Y#,6&' D#$/6#1/&' EP)*/.&' QHYDER4' -*' 9#,6&' ,#3 J-$H)1+2$1)*0+),02$%,07)'2$(&#1+,)$&*)$;KLM$ $/6#1/&'2P)*/.&'#*.#$=0'*&,'oh>Kah'+/**&$-,'%-'-"3 1&%#,02,$)-$%53-0/2 1&,' -$' aKcd>' H,6#' ./<1#' ,"2&$-' J>adc' +/**&$-,' %-' H$' *&,' P*6/+&,' %/-=' #;&,' QaKKd3aKcdR4' -*' 9#,6&' -"1&,'+-$&,'8"-'-*'%#6&'2")*/.#%&'2&1'*#'b!VH>' ,#$/6#1/&' 21/7#%&' (#' -7&*"./&$#%&' #' "$#' 6#,#' %-' .1-./+/-$6&' #$"#*' .&+2"-,6&' Q!]YZR' %-*' jL>' H*' /$<&1+-' -C2*/.#' 8"-' *#' %/<-1-$./#' -$' *#' ./3 OI$' .1-./+/-$6&' .&$,6#$6-4' 2&,/6/7&4' ,0*/%&' 5' <1#' %-' 9#,6&' ,#$/6#1/&' &<1-./%#' 2&1' *#' b!VH' ,&,6-$/%&' -$' *&,' %/-=' #;&,' %-' *#' ,-1/-O4' ,-;#*#$>' 5' -*' ^/$/,6-1/&' %-' D#$/%#%' 21&7/-$-' %-' *#' E&1' ,"' 2#16-4' -*' 9#,6&' ,#$/6#1/&' 2P)*/.&4' 2&1' ,"' +-6&%&*&9:#' ",#%#' 2#1#' ,"' -,6/+#./0$> Página 18 · www.isanidad.com · Sanidad Privada. Mayo 2021

ado en España se sitúa media de la OCDE ?#' HYDE' P$/.#+-$6-' .&$,/%-1#' -*' 9#,6&' 1-#*/3 =#%&' &' </$#$./#%&' 2&1' #9-$6-,' ,#$/6#1/&,' 2P3 )*/.&,4' 5' ,",' +B6&%&,' %-' -*#)&1#./0$' 5' &)A-6/3 7&,' (#$' ,/%&' 2#.6#%&,' -$61-' *#,' &19#$/=#./&$-,' 6-11/6&1/#*-,' 5' $&' 6-11/6&1/#*-,' /$6-91#%#,' -$' -*' D/,6-+#' T#./&$#*' %-' D#*"%>' E&1' -**&4' -,' O.&(-3 1-$6-' #' $/7-*' $#./&$#*' 5' 2"-%-' "6/*/=#1,-' 2#1#' .&+2#1#./&$-,' -$61-' .&+"$/%#%-,' #"60$&+#,O>'

%-' *&,' ,/,6-+#,' ,#$/6#1/&,' $#./&$#*-,>' D-' "6/*/3 =#4' 2&1' 6#$6&4' 2#1#' .&+2#1#./&$-,' -$61-' H,6#%&,>' ?#'%/<-1-$./#'-$'*#'./<1#'%-'9#,6&',#$/6#1/&'&<1-./%#' 2&1' *#' b!VH' 5' -*' ^/$/,6-1/&' %-' D#$/%#%' 21&7/-3 $-' %-' *#' +-6&%&*&9:#' ",#%#' 2#1#' ,"' -,6/+#./0$> H*' /$<&1+-' 6#+)/B$' 1-.&9-' 8"-' -*' 9#,6&' -$' ,#$/3 6#1/&'21/7#%&',-',/6P#'-$'-*'a4oL'%-*'EXi>'H$'.&$3 .1-6&4' -*' %/$-1&' %-' )&*,/**&' 1-21-,-$6#' -*' aL' %-*' EXi' -$' aKcM4' -*' ,-9"1&' 21/7#%&' -*' K4kL' 5' -*' 9#,3 6&' %-' /$,6/6"./&$-,' ,/$' @$/+&' %-' *".1&' -*' K4KjL>'

OH,6-' %-,9*&,-' 2&1.-$6"#*' %-*' 9#,6&' ,#$/6#1/&' 21/3 7#%&' $&' %/</-1-' 21@.6/.#+-$6-' %-*' &),-17#%&' 4&8=-'&0'D%-%*+&,%/'$&'4#-%$#$L' -$' #;&,' #$6-1/&1-,S4' #2"$6#$>' ],/+/,+&4' -C/,3 &0'8#*+/'*#-%+#,%/'(=C0%./'#0.#-Y<'0/*'_?O@K?' 6-' "$' 2&1.-$6#A-' %-*' 9#,6&' ,#$/6#1/&' 2P)*/.&' 8"-' 1%00/-&*'$&'&),/*'&-'K@MV ,-' %-,6/$#' #' *#' </$#$./#./0$' %-' 21&7/,/0$' 21/3 7#%#' #' 61#7B,' %-' .&$./-16&,>' H$' aKcd' ,-' ,/6P#' -$' ]*9"$&,' &19#$/,+&,' /$6-1$#./&$#*-,' .&+&' *#' -*' cK4oL4' "$' K4JL' +-$&,' 8"-' -$' -*' #;&' aKcM> b!VH4'*#'b^D'&'*#'H"1&,6#6'."-$6#$'.&$'-*'D/,3 6-+#' %-' !"-$6#,' %-' D#*"%' QD!DR' 2#1#' *#' 1-.&9/3 J0'8#*+/'*#-%+#,%/'&-'(,/F%*%<-'(,%F#$#L' %#' 5' 61#6#+/-$6&' %-' *#' /$<&1+#./0$' ,&)1-' 9#,6&' *&8=-'0#*'&*+%1#.%/-&*',&#0%Y#$#*L'#*.%&-$&' ,#$/6#1/&>' ],:4' %/.(&,' &19#$/,+&,' *&91#$' 8"-' *#' #0'KLPA'$&0'\Q]'&-'K@MV /$<&1+#./0$' 2"-%#' ,-1' .&+2#1#)*-' -$61-' *&,' 2#:3 ,-,'+/-+)1&,'%-'-,6#,'&19#$/=#./&$-,>''H,6-',/,6-3 H$'6B1+/$&,'%-'EXi4',-'-,6/+#'8"-'-,6#'2#16/%#'%-' +#',-'"6/*/=#'2#1#'O.&+2#1#./&$-,'-$61-'H,6#%&,O> .&$./-16&,' ,"2&$-' -*' K4oL>' V-' -**&,4' -*' K4hL' .&3 11-,2&$%-'#'*#,'.&+"$/%#%-,'#"60$&+#,4'-*'K4caL' H*' D!D' ,-' )#,#' -$' .*#,/</.#./&$-,' 5' +B6&%&,' 2#.3 #'*#,'+"6"#*/%#%-,'%-'<"$./&$#1/&,'5'-*'K4KJL'1-,3 6#%&,' -$' &19#$/=#./&$-,' /$6-1$#./&$#*-,' 8"-' 6#$6-' #*' D/,6-+#' %-' D-9"1/%#%' D&./#*>' H*' /$<&1+-' #<-.6#$' #' *&,' H,6#%&,' +/-+)1&,' %-' *#,' +/,+#,4' -' -,6/+#'8"-'-*'9#,6&',#$/6#1/&'6&6#*'-$'21&7/,/0$'21/3 /$.*"5-' -*' 9#,6&' %-' *&,' #9-$6-,' 21/7#%&,4' ,/$' -$3 7#%#'#,./-$%-'#*'j4JL'%-*'EXi'-$'aKcM>'H,6&',"2&3 61#1' -$' .&$,/%-1#./&$-,' ,&)1-' *#' &19#$/=#./0$' $-'"$'9#,6&'.-1.#$&'#'*&,'JK>Kdc'+/**&$-,'%-'-"1&,> Mayo 2021. Sanidad Privada · www.isanidad.com · Página 19

Telemedicina, Inteligencia Artificial y Big Data, los principales retos del Sistema Nacional de Salud para afrontar su digitalización

*' 21&.-,&' %-' %/9/6#*/=#./0$' %-*' D/,6-3 +&%-1$/=#1'$"-,61#'D#$/%#%>'],/+/,+&4'$&,'(#'-$,-3 +#' T#./&$#*' %-' D#*"%' QDTDR' ,-' (#' 7/,6&' /+2"*,#3 ;#%&'8"-'*&,',/,6-+#,'8"-'(#$'#2&,6#%&'2&1'*#'/$$&3 %&' %-,%-' 8"-' /11"+2/0' *#' 2#$%-+/#' %-' !&7/%3cd>' 7#./0$'5'2&1'*#'%/9/6#*/=#./0$',&$'*&,'+@,'1-,/*/-$6-,' %-,%-'-*'2"$6&'%-'7/,6#',&./&,#$/6#1/&'5'-.&$0+/.&S> ],:4' *#' $-.-,/%#%' %-' -7/6#1' .&$6#.6&' <:,/.&' -$61-' 2-1,&$#,' (#' <#7&1-./%&' *#' "6/*/=#./0$' %-' *#,' ,&*"3 H*' -7-$6&4' 6/6"*#%&' q?#' _1#$,<&1+#./0$' %/9/6#*' %-' ./&$-,' %/9/6#*-,' 2#1#' 61#6#1' %-' +#$6-$-1' *#' .#*/%#%' *#',#$/%#%r4'(#',/%&'&19#$/=#%&'2&1'W-$/$'5'*#'/$,6/3 %-' *#' #6-$./0$' ,#$/6#1/#>' H$' -,6-' ,-$6/%&4' ^ª' ?"=' 6"./0$' #.#%B+/.#' H,#%->' V"1#$6-' -*' #.6&4' *&,' #,/,3 ?02-=3!#11#,.&4' 21-,/%-$6#' %-' W-%-1#./0$' H,2#3 6-$6-,' (#$' #$#*/=#%&' *&,' 1-6&,' #' *&,' 8"-' ,-' -$<1-$6#' ;&*#' %-' H+21-,#,' %-' _-.$&*&9:#' D#$/6#1/#' QW-$/$R4' -*' D/,6-+#' T#./&$#*' %-' D#*"%' 2#1#' 2&%-1' **-7#1' #' (#' #F1+#%&4' %"1#$6-' -*' ppp`X' -$."-$61&' %-*' D-.3 .#)&' -*' 2#,&' #' *#' +&%-1$/=#./0$' 5' %/9/6#*/=#./0$' 6&1'%-'*#'_-.$&*&9:#'D#$/6#1/#4'8"-'O*#'2#$%-+/#'%-' %-*' ,-.6&1' ,#*"%4' -$61-' *&,' 8"-' %-,6#.#1&$' -*' i/9' !&7/%3cd' (#' #.-*-1#%&' 7#1/&,' #;&,' *#' $-.-,/%#%' %-' V#6#4' *#' _-*-+-%/./$#' 5' *#' X$6-*/9-$./#' ]16/F./#*> Página 20 · www.isanidad.com · Sanidad Privada. Mayo 2021

4&8=-'7<(&YGW#,,#*./L'&*'-&.&*#,%/' ,&`&a%/-#,'*/C,&'.<1/'.#$#')-/'$&'0/*'#8&-+&*' $&'0#'.#$&-#'*#-%+#,%#'()&$&'./0#C/,#,'X#.%#' 0#'$%8%+#0%Y#.%<-'$&0'4%*+&1#'"#.%/-#0' $&'4#0)$

61".6"1#,4' *#' $-.-,/%#%' %-' %/,2&$-1' %-' 1-2&,/6&1/&,' %-' /$<&1+#./0$' %-' .#*/%#%4' 5' *#' $-.-,/%#%' %-' .&+3 2#16/1' %#6&,' %-' .#*/%#%' -$' 6/-+2&' 1-#*4' -$61-' &61&,>

e#0/' e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

K%-0/)/04*$'#$-)$'0H0+)-0N)/04*$<$-)$E*+#-0H#*/0)$ K,+0>/0)-$OEKP g$9-*' D@$.(-=' ]1/,6/4' %/1-.6&1' 9-$-1#*' %-' V/9/3 6#*/=#./0$' -' X$6-*/9-$./#' ]16/F./#*4' %-*' ^/$/,6-1/&' %-' ],"$6&,' H.&$0+/.&,' 5' _1#$,<&1+#./0$' V/9/3 6#*4' ,-' (#' .-$61#%&' -$' *#' #2*/.#./0$' %-' *#' X$6-*/9-$3 ./#' ]16/F./#*>' D&)1-' *#' 61#$,<&1+#./0$' %/9/6#*4' -,6-' P*6/+&' (#' #2"$6#%&' 8"-' ,-' 61#6#' %-' "$#' $-.-,/%#%>'

OT&'.&$,/,6-',&*&'-$'.&$6#1'.&$'*#,'+-A&1-,'6-.$&*&9:#,4' ,/$&'-$'"$'.#+)/&'%-'+-$6#*/%#%'/+2&16#$6-S>'D-9P$' (#'-C21-,#%&4'*#'+#%"1-='%/9/6#*'%-'*&,',-17/./&,'%-' ,#*"%'-,')#A#4'.&$'"$'$/7-*'/$./2/-$6-'%-',/,6-+#,'#$#3 *:6/.&,4'"$'$P+-1&'-*-7#%&'%-')#,-,'%-'%#6&,'%/<-1-$3 H$' -,6-' 2"$6&4' (#' 1-.&1%#%&' ?02-=3' !#11#,.&' 8"-' 6-,4'2*#6#<&1+#,'$&'/$6-91#%#,'5'-,.#,#'/$6-1.&$-C/0$>' W-$/$'(#'-*#)&1#%&',"'q21&5-.6&'%-'%/+-$,/0$'2#:,r>' O]'2-,#1'%-*'-,<"-1=&'2&1'#*.#$=#1'*#'/$6-1&2-1#)/*/3 H*'&)A-6/7&'-,'2&$-1',&)1-'*#'+-,#'%-'*#,'#%+/$/,61#3 %#%4'#2-$#,',-'(#$'&)6-$/%&'1-,"*6#%&,S4'(#'1-.#*.#%&> ./&$-,'<01+"*#,'-F.#.-,'5'1-#*/,6#,'2#1#'61#$,<&1+#1' 5'%/9/6#*/=#1'-*'DTD'5'-*'6-A/%&'-+21-,#1/#*',#$/6#1/&> ],:4' .&$,/%-1#' 8"-' *#' 61#$,<&1+#./0$' %/9/6#*' %-)-' #2*/.#1,-' #' 6&%&,' *&,' $/7-*-,' #,/,6-$./#*-,4' J0'b\,/H&.+/'$%1&-*%<-'(#:*cL'&0#C/,#$/' 8"-' *#' /$<&1+#./0$' %-)-' ,-1' .&+2#16/%#' 5' #.3 (/,'d&-%-L'(,&+&-$&'(/-&,'*/C,&'0#'1&*#'$&'0#*' .-,/)*-' 5' -,' <"$%#+-$6#*' *#' .&&1%/$#./0$' -$61-' #$1%-%*+,#.%/-&*';<,1)0#*'&9.#.&*'H',&#0%*+#*' *&,' #.6&1-,' 2P)*/.&,4' 21/7#%&,' 5' *#' ./"%#%#$:#>' (#,#'+,#-*;/,1#,'H'$%8%+#0%Y#,'&0'4"4 Z-,2-.6&' #' *#' X$6-*/9-$./#' ]16/F./#*4' #F1+#' 8"-' O)/-$' "6/*/=#%#' -,' "$#' (-11#+/-$6#' +"5' 2&6-$3 E&1' ,"' 2#16-4' Y#*&' Y"6/B11-=4' %/1-.6&1' 9-$-1#*' 6-' 8"-' 2"-%-' #5"%#1' +".(&' -$' *#' 61#$,<&1+#./0$' %-' X$%",61/#' 5' %-' *#' E5+-' %-*' ^/$/,6-1/&' %-' X$3 %-*' ,/,6-+#' ,#$/6#1/&>' ?#' X]' 21&2&1./&$#' ,/,6-3 %",61/#4' !&+-1./&' 5' _"1/,+&4' (#' %-,6#.#%&' 8"-' +#,' %-,.1/26/7&,' 5' 21-%/.6/7&,4' &<1-.-' %/#9$0,6/.&,' *#' %/9/6#*/=#./0$' O-,' "$&' %-' *&,' 1-6&,' +@,' /+2&13 +@,' 1@2/%&,' 5' 21-./,&,' 5' +-A&1#' *#' .#*/%#%' #,/,3 6#$6-,' #' *&,' 8"-' ,-' -$<1-$6#' -*' ,-.6&1' ,#$/6#1/&S>' 6-$./#*4' -$' 6&%&,' *&,' 2"$6&,' %-' *#' .#%-$#' %-' 7#*&1S> E&1' -**&4' (#' %-,6#.#%&' *#' $-.-,/%#%' %-' 9#1#$3 !7#'+,#-*;/,1#.%<-'$%8%+#0'*&'+,#+#'$&')-#' 6/=#1' "$' +#1.&' $&1+#6/7&' 2#1#' "$#' #%-."#3 -&.&*%$#$O' "/' ./-*%*+&' */0/' &-' ./-+#,' ./-' 0#*' %#' ,#$/%#%>' ]%-+@,' %-' .1-#1' "$#' 1-%' -,6#$3 1&2/,&*' +&.-/0/8:#*L' *%-/' &-' )-' .#1C%/' $&' %#1/=#%#' 8"-' .&+2#16#' %#6&,' .*:$/.&,' 2#1#' *#' 1&-+#0%$#$'%1(/,+#-+&3L'X#'#()-+#$/' /$7-,6/9#./0$4'O5'*#'$-.-,/%#%'%-'/+2"*,#1'*#'.1-#./0$' %-'"$'1-2&,/6&1/&'5')"-$#,'21@.6/.#,'%-',#*"%'%/9/6#*S> _&%&' -,6&' #5"%#' #' *#' 6&+#' %-' %-./,/&$-,>' D-9P$' D@$.(-=' ]1/,6/4' (#5' "$' *#19&' .#+/$&' 2&1' 1-.&11-1' O?#'.1/,/,',#$/6#1/#'(#'2"-,6&'%-'+#$/F-,6&'-,6#,'%-3 -$' X]' 8"-' 7#' #' 2-1+/6/1' #7#$=#1' %-' +#$-1#' -,61#3 )/*/%#%-,' 5' 2&1' -**&' -,' $-.-,#1/#' "$#' 6&6#*' 61#$,<&13 6&,<B1/.#>' I$&' %-' *&,' /$,61"+-$6&,' %-' *&,' 8"-' ,-' +#./0$'%/9/6#*O4'(#'%-,6#.#%&>'H$61-'-,6#,'%-)/*/%#%-,' 7#*-' *#' ]%+/$/,61#./0$' 2#1#' .&$,-9"/1*&' -,' *#' -,3 (#' $&+)1#%&' #,2-.6&,' .&+&' *#' 1/9/%-=4' <#*6#' %-' 1-3 61#6-9/#' $#./&$#*' %-' X$6-*/9-$./#' ]16/F./#*4' 8"-' .&3 ."1,&,'("+#$&,'5'F$#$./-1&,4'*#'.#1-$./#'%-'/$<1#-,3 +-$=#1@' #' %-,#11&**#1,-' #' 2#16/1' %-*' 210C/+&' A"$/&> Mayo 2021. Sanidad Privada · www.isanidad.com · Página 21

Q)$#.%)*104*$'#$-)$+#-#(#'0/0*) ?#' 6-*-+-%/./$#4' ."5#' "6/*/=#./0$' (#' -C2-1/+-$3 6#%&' "$' .1-./+/-$6&' -C2&$-$./#*' -$' 6/-+2&,' %-' !&7/%3cd4' (#' ,/%&' -*' &61&' %-' *&,' 6-+#,' #)&1%#%&,' %"1#$6-' -*' -7-$6&>' ],:4' *#' 7/,/0$' %-' *&,' 2#./-$6-,' *#' (#' #2&16#%&' -*' V1>' f&,B' ?"/,' i#8"-1&4' %/1-.6&1' 5' .&&1%/$#%&1' ./-$6:F.&' %-*' W&1&' H,2#;&*' %-' E#3 ./-$6-,' 5' 2#61&$&' %-' *#' W"$%#./0$' _-.$&*&9:#' 5' D#*"%>' ]' ,"' 2#1-.-14' *#' 2#$%-+/#' (#' 2"-,6&' -$' 7#3 *&1' *#' 6-.$&*&9:#' 5' +"5' -,2-./#*+-$6-' *#,' _-.$&*&3 9:#,' %-' *#' X$<&1+#./0$' 5' *#' !&+"$/.#./0$' Q_X!,R>

+-%/./$#' *#$=#%#,' 2&1' i#1.-*&$#' N-#*6(' N")4' .&$' *#' .&*#)&1#./0$' %-' H,#%-' !1-#2&*/,' 5' -*' X$,6/6"6&' %-' Y-,6/0$' D#$/6#1/#' %-' H,#%-4' (#' ,/%&' -*' 21&5-.3 6&' sU&E#./-$6-V/9/6#*4' +-%/#$6-' -*' 8"-' ,-' (#' -*#3 )&1#%&' "$' -,6"%/&' ,&)1-' *#' .&$,"*6#' %-' ,#*"%' 7/13 6"#*' 5' ,",' )-$-F./&,' 2#1#' *&,' ,/,6-+#,' ,#$/6#1/&,>

],/+/,+&4' (#' #2"$6#%&' 8"-' -*' ",&' %-*' 6-*B<&$&' -,' %-*' 6&%&' /$,"F./-$6-' .&+&' 6-*-+-%/./$#>' b61&' #,3 2-.6&'8"-'(#'%-,6#.#%&'-,'8"-',-'(#'21&%"./%&'"$#' "$/%/1-../&$#*/%#%4' %-,%-' -*' .-$61&' ,#$/6#1/&' #*' 2#3 ./-$6->' E&1' -**&4' 7-' $-.-,#1/&' 2&6-$./#1' -*' .&$6#.3 6&' %-' -,6-' P*6/+&' .&$' *&,' 21&<-,/&$#*-,' ,#$/6#1/&,>

D-9P$'*&,'1-,"*6#%&,'%-'-,6-'61#)#A&4'-*'%-,#11&**&'%-'*#' 6-*-+-%/./$#'2#,#'2&1'"$'.#+)/&'%-'*#'$&1+#6/7#'$#3 ./&$#*',&)1-'-,6-'@+)/6&4'8"-'#%+/6#'-*'",&'%-'-,6#,'(-3 11#+/-$6#,'.&$'9#1#$6:#,'2#1#'-*'2#./-$6-4'-*'2-1,&$#*' ,#$/6#1/&'5'-*'.&$A"$6&'%-'*#',#$/%#%e'5'2&1'(#.-1'2#13 6:./2-,'%-'-,6#'$"-7#'+&%#*/%#%'#,/,6-$./#*'#'*#,'&19#3 $/=#./&$-,'%-',#*"%4'#'*#',&./-%#%'5'#'6&%&,',",'#.6&1-,>

E&1' ,"' 2#16-4' ?"/,' i#%1/$#,4' %/1-.6&1' -A-."6/7&4' i!T' N-#*6(' N")4' (#' -C2"-,6&' 8"-' *#,' 6-.$&*&9:#,' %/9/6#*-,' 2-1+/6-$' *#' 61#=#)/*/%#%>' ]%-+@,4' &2/$#' 8"-' *#' O61#$,<&1+#./0$' %/9/6#*' %-' *#' ,#*"%' 2#,#' 2&1' 2&,/./&$#1' #*' 2#./-$6-' -$' -*' .-$61&' %-' #6-$./0$S>' H$' -,6-' ,-$6/%&4' "$#' %-' *#,' /$/./#6/7#,' ,&)1-' 6-*-3

Página 22 · www.isanidad.com · Sanidad Privada. Mayo 2021

7#'+&0&1&$%.%-#'$&C&'(,&*&,F#,'&0'0#$/'X)1#G -/'$&'0#'#+&-.%<-'*#-%+#,%#'H'$&C&' $&'%-./,(/,#,*&'0#'F/Y'$&'0/*'(#.%&-+&*' &-'&0'$%*&T/'$&'0#*'X&,,#1%&-+#*'+&.-/0<8%.#*

E&1' P*6/+&4' !1/,6/$#' i-,.0,4' %/1-.6&1#' 9-$-1#*4' HX_' N-#*6(' D2#/$4' (#' 1-.&1%#%&' 8"-' *#' 6-*-+-3 %/./$#' 5#' -,6#)#' #$6-,' %-' *#' !&7/%3cd>' ],:4' i-,3 .0,' (#' .&$.*"/%&m' O_&%&,' %-)-+&,' 2-$,#1' -$' &61#' %/+-$,/0$e' 5#' 7#+&,' 6#1%-' -$' 6-+#,' %-' X]O>

Hospitales e industria colaboran en España en más de 170 ensayos clínicos con 28.000 pacientes

#'2#$%-+/#'(#'#.-1.#%&'-*'.&$.-26&'%-'-$3 ,#5&' .*:$/.&' #' *#' ,&./-%#%>' E1-./,#+-$6-' -,6-' A"-7-,' aK'%-'+#5&',-'.-*-)1#'-*'V:#'^"$%/#*'%-'*&,'H$,#5&,' !*:$/.&,4'.*#7-,'-$'*#'#.6"#*/%#%'-$'*#'*".(#'.&$61#'-*' !&7/%3cd>'?#'.&*#)&1#./0$'-$61-'*#'/$/./#6/7#'2P)*/.#' 5'*#'21/7#%#4'O(#'.&$7-16/%&'#'H,2#;#'-$'"$'2#:,'%-' 1-<-1-$./#'-$'*#'1-#*/=#./0$'%-'-$,#5&,'.*:$/.&,S4'-C2*/3 .#'f#7/-1'I1=#54',")%/1-.6&1'9-$-1#*'%-'W#1+#/$%",3 61/#' 5' .&21-,/%-$6-' %-' *#' E*#6#<&1+#' _-.$&*09/.#' %-' ^-%/.#+-$6&,' X$$&7#%&1-,>' O?#' 91#$' +&7/*/=#./0$' Página 24 · www.isanidad.com · Sanidad Privada. Mayo 2021

/$7-,6/9#%&1#' 2&1' )",.#1' "$#' ,&*"./0$' 6-1#2B"6/.#' <1-$6-' #*' .&1&$#7/1",' .&$,6#6#' -,6#' 1-#*/%#%S4' #;#%-> V-'(-.(&4'H,2#;#',-'(#'.&$7-16/%&'-$'-*'."#16&'2#:,'%-*' +"$%&'5'21/+-1&'%-'H"1&2#'-$'-$,#5&,'.*:$/.&,'.&$61#' -*'.&1&$#7/1",>'!&+2#;:#,'<#1+#.B"6/.#,'5'(&,2/6#*-,' -$'H,2#;#'2#16/./2#$'-$'*#'#.6"#*/%#%'-$'+@,'%-'coK' -,6"%/&,'%-'2&6-$./#*-,'61#6#+/-$6&,'5'7#."$#,4'-$'#*3 1-%-%&1'%-'coK'(&,2/6#*-,'-,2#;&*-,4'2P)*/.&,'5'21/7#3 %&,4'8"-'(#$'*&91#%&'/+2*/.#1'#'"$&,'aM>KKK'2#./-$6-,>

W/1(#T:#*';#,1#.I)+%.#*'H'X/*(%+#0&*' &-'J*(#T#'(#,+%.%(#-'&-'0#'#.+)#0%$#$'&-'1[*' $&'M_@'&-*#H/*'.0:-%./*'$&'(/+&-.%#0&*' +,#+#1%&-+/*'H'F#.)-#*

%-' XlV' 8"-' W#1+#/$%",61/#' 1-#*/=#' .#%#' #;&' -$61-' ,",'#,&./#%&,>'],/+/,+&4'*#'/$7-1,/0$'%-'*#'/$%",61/#' -$' /$7-,6/9#./0$' (#' #"+-$6#%&' #' "$' 1/6+&' +-%/&' #$"#*'#."+"*#6/7&'%-*'J4ML'-$'*&,'P*6/+&,'cK'#;&,>

H,6-'/+2"*,&4'*/9#%&'#'*#'2#$%-+/#'2-1&'6#+)/B$'#*' -,<"-1=&'/$7-,6/9#%&1'%-'*#,'.&+2#;:#,'/$$&7#%&1#,' -$'-*'1-,6&'%-'@1-#,'6-1#2B"6/.#,4'(#'2-1+/6/%&'8"-'-$' aKaK',-'(#5#',"2-1#%&'*#'./<1#'1B.&1%'%-*'+/**#1'%-'-$3 ,#5&,'.*:$/.&,'#"6&1/=#%&,'2&1'*#']9-$./#'H,2#;&*#'%-' ^-%/.#+-$6&,' 5' E1&%".6&,' D#$/6#1/&,' Q]-+2,R>' H$' .&$.1-6&4'%-'*&,'c>Kcd'-,6"%/&,'#21&)#%&,4'-*'jJL'.&3 11-,2&$%-$'#'+-%/.#+-$6&,'2#1#'61#6#1'%/<-1-$6-,'6/3 2&,'%-'.@$.-14',-9"/%&,'%-'*&,'-$,#5&,'2#1#'!&7/%3cd>

7#'%-$)*+,%#';#,1#.I)+%.#'#*&-+#$#' &-'J*(#T#'(,/1)&F&'/.X/'$&'.#$#'$%&Y '&-*#H/*'.0:-%./*

OV-' $"-7&' *#' .&*#)&1#./0$' -$61-' *#' ]%+/$/,61#./0$' ,#$/6#1/#4'#'61#7B,'%-'*#']-+2,4'*&,'.*:$/.&,'-'/$7-,6/3 9#%&1-,4'*&,'2#./-$6-,'5'*#,'.&+2#;:#,'<#1+#.B"6/.#,' (#',/%&'.*#7-'$&',0*&'2#1#'1-,2&$%-1'.&$'1#2/%-='#'*#' 2"-,6#'-$'+#1.(#'%-'-$,#5&,'%-'61#6#+/-$6&,'.&$61#' *#' !&7/%3cd' t,-;#*#' I1=#534' ,/$&' 2#1#' 8"-' *#' .1/,/,4' .&$' *&,' .&*#2,&,' -$' *&,' (&,2/6#*-,' 5' *#,' +-%/%#,' %-' .&$F$#+/-$6&4' $&' <1-$#1#' *#' /$7-,6/9#./0$' -$' 2#6&3 *&9:#,'$&'!&7/%>'H,'"$'BC/6&'%-'6&%&,'8"-'+"-,61#'*#' ,&*/%-='%-*'+&%-*&'-,2#;&*'%-'/$7-,6/9#./0$'.*:$/.#S>

V-'-,&,'ocj'+/**&$-,'/$7-16/%&,'-$'/$7-,6/9#./0$'.*:3 $/.#4'"$'jk4hL'5#'.&11-,2&$%-'#'<#,-,'6-+21#$#,'QX' 5'XXR>'H,6#'21&2&1./0$'.1-.-'%-'<&1+#'.&$,6#$6->'V-' (-.(&4' ,-9P$' 1-7-*#$' *&,' P*6/+&,' %#6&,' %-*' E1&5-.3 6&' iHD_4' /$/./#6/7#' %-' W#1+#/$%",61/#' 2#1#' /+2"*3 ,#1'*#'/$7-,6/9#./0$'.*:$/.#'-$'H,2#;#4'-*'hkL'%-'*&,' -$,#5&,' 21&+&7/%&,' -*' #;&' 2#,#%&' 2&1' .&+2#;:#,' <#1+#.B"6/.#,' -$' $"-,61&' 2#:,' 5#' ,-' .&11-,2&$%-$' .&$' *#,' <#,-,' 6-+21#$#,>' H,' "$' 91#$' /+2"*,&' 2#1#' ,/6"#1' #' H,2#;#' .&+&' "$#' 1-<-1-$./#' /$6-1$#./&$#*' -$' -*' .#+2&' %-' *#' /$7-,6/9#./0$' .*:$/.#' 6-+21#$#>

?&' +@,' /+2&16#$6-' %-' -,6#' 1-#*/%#%' -,' *#' +"*6/2*/3 .#./0$' %-' &2&16"$/%#%-,' 2#1#' *&,' 2#./-$6-,>' H$' *#' P*6/+#' %B.#%#4' H,2#;#' (#' 2#16/./2#%&' -$' +@,' %-' j>JKK' -$,#5&,' .*:$/.&,4' -$' *&,' 8"-' (#$' 6&+#%&' 2#13 6-' cJh>KKK' 2#./-$6-,>' OD&$' 2#./-$6-,' -,2#;&*-,' 8"-' ?#' /$%",61/#' <#1+#.B"6/.#' #,-$6#%#' -$' H,2#;#' 21&3 -,6@$' 61#6@$%&,-' .&$' *&,' 8"-' ,-1@$' *&,' +-%/.#+-$3 +"-7-'&.(&'%-'.#%#'%/-='-$,#5&,'.*:$/.&,>'?#,'.&+2#3 6&,' %-*' <"6"1&S4' #F1+#' f#7/-1' I1=#5>' OU' -,6-' #..-,&' ;:#,'%-%/.#$'#'-,6#'#.6/7/%#%'-*'kKL'%-'6&%#'*#'/$7-13 6-+21#$&' %-' *&,' 2#./-$6-,' #' *&,' $"-7&,' 61#6#+/-$3 ,/0$'%-,6/$#%#'#'*#'XlV'%-'$"-7&,'+-%/.#+-$6&,>'V-' 6&,' 3#;#%-3' -,' #P$' +@,' /+2&16#$6-' -$' *&,' .#,&,' %-' *&,'c>acc'+/**&$-,'8"-',-'/$7/16/-1&$'-$'aKcd'3+@C/3 2#6&*&9:#,'91#7-,'8"-'$&'(#$'1-,2&$%/%&'#'*#,'6-1#3 +&' (/,601/.&34' +@,' %-' ocj' ,-' %-%/.#1&$' #' -,6"%/&,' 2/#,' 5#' #21&)#%#,4' 2"-,6&' 8"-' 2"-%-' ,-1' *#' P*6/+#' .*:$/.&,4',-9P$'*#'P*6/+#'H$."-,6#',&)1-'].6/7/%#%-,' &2&16"$/%#%' %-' ."1#' &' .&$61&*' %-' *#' -$<-1+-%#%S>

Mayo 2021. Sanidad Privada · www.isanidad.com · Página 25

Novo Nordisk ha puesto en marcha en España 36 ensayos con 1.274 pacientes en cinco años

esde 2016, Novo Nordisk España ha invertido 20 millones de euros en I+D. Esta cuantía económica le ha permitido promover la ejecución de un total de 36 ensayos clínicos, con la participación de 1.274 pacientes. La compañía confía en aumentar en los próximos años este esfuerzo inversor al precisar de un número más elevado de pacientes y centros.

Gracias a la investigación clínica, desde Novo Nordisk contribuimos activamente con el desarrollo de nuevos medicamentos y mantenemos nuestra responsabilidad de evaluar con rigor nuestros productos para documentar su eficacia y seguridad”.

Desde 2016, Novo Nordisk España ha invertido 20 millones de euros en I+D para la realización Más de 3,5 millones de personas viven con diabede ensayos clínicos tes en España y en los próximos 25 años se superarán los 4 millones. Como explica Fernando Fuentes, jefe de Operaciones Clínicas de Novo Nordisk en España, “a pesar de las mejoras en las opciones de tratamiento de la diabetes, existe aún una clara necesidad de una mejor prevención y tratamiento. Página 26 · www.isanidad.com · Sanidad Privada. Mayo 2021

El valor compartido de la investigación clínica La investigación clínica es un proceso que incluye la colaboración entre la industria, los hospitales, los pacientes, los profesionales sanitarios, los gobiernos y las autoridades sanitarias. Novo Nordisk, en un estudio

global, ha constatado que la creación de valor es más cree que los ensayos clínicos contribuyen a mejoenriquecedora para todas las partes interesadas cuan- rar de forma general el tratamiento y la asistencia. do estas se centran a la vez en las necesidades médicas. Todo esto pone en evidencia para el jefe de OperacioEn base a ello, el valor que aporta dicha investiga- nes Clínicas de Novo Nordisk en España que, “la labor ción a cada colaborador en la misma es claro. Sobre de colaboración directa, estable y a largo plazo con los pacientes, Fernando Fuentes considera que, “su nuestros centros u hospitales donde realizamos los enparticipación en ensayos clínicos hace posible que sayos, contribuye a una mayor implicación de los mése dispongan de más y mejores tratamientos para dicos en el acceso a la innovación terapéutica. Tanto la diabetes, hemofilia y otras áreas terapéuticas”. es así, que incluso ambas partes compartimos el objetivo principal de mejorar la calidad de vida de los paEn concreto, el 74% de los profesionales sanita- cientes con diabetes, hemofilia y otras enfermedades”. rios coinciden en que los beneficios de la participación para los pacientes se extienden más El valor de la investigación a la sociedad allá de la duración del ensayo clínico. Mien- La investigación clínica tiene también un impacto tras que el 71% de las personas con diabetes de- positivo en la economía del entorno. Da lugar a la claran haber mejorado sus hábitos alimentarios creación de puestos de trabajo, así como a la mejocomo resultado de su participación en el ensayo. ra de la economía sanitaria. Además, ayuda a impulsar el progreso científico y aporta valor a la sociedad.

El 74% de los profesionales coincide en que los beneficios de la participación para los pacientes Al mismo tiempo, los avances científicos se dise extienden más allá de la duración del ensayo funden a través de las redes y publicaciones cien-

tíficas. Esto promueve mejores prácticas en asisAsimismo, las habilidades que adquieren los pro- tencia. A pesar de todo, “la investigación clínica fesionales de la salud ayudan a participar en la puede crear aún más valor para todas las partes ininvestigación clínica, conducir a mejoras en la teresadas y para la sociedad en general. Para ello, atención del paciente y en la realización de investi- es fundamental trabajar hacia la consecución de gaciones en hospitales y clínicas. De hecho, el 75% objetivos comunes”, concluye Fernando Fuentes. Mayo 2021. Sanidad Privada · www.isanidad.com · Página 27

Página 20 · www.isanidad.com · Sanidad Privada. Marzo 2021

Sanidad Privada 29 - Mayo 2021

Articles inside

NOVO NORDISK

ASEGURAMIENTO SANITARIO